Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Lovenox
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 1,481
2018 Revenue in Millions : 1,597
Growth (%) : -7
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 1,634
2019 Revenue in Millions : 1,644
Growth (%) : -1
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 1,636
2020 Revenue in Millions : 1,473
Growth (%) : 10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 1,437
2021 Revenue in Millions : 1,636
Growth (%) : -12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 1,214
2022 Revenue in Millions : 1,437
Growth (%) : -14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anticoagulants
Currency : USD
2014 Revenue in Millions : -0.20%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Anticoagulants
Currency : USD
2015 Revenue in Millions : 1,869
2014 Revenue in Millions : 1,891
Growth (%) : 1%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Blood Disorders
Currency : USD
2016 Revenue in Millions : 1,734
2015 Revenue in Millions : 1,822
Growth (%) : -5
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Blood Disorders
Currency : USD
2017 Revenue in Millions : 1,953
2016 Revenue in Millions : 2,029
Growth (%) : -4
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 1,655
2017 Revenue in Millions : 1,780
Growth (%) : -7%
LOOKING FOR A SUPPLIER?